Try our Advanced Search for more refined results
Health
-
January 02, 2026
Marijuana And Hemp Policy Enters Uncharted Waters In 2026
The final weeks of 2025 produced two monumental shifts poised to reshape the cannabis policy landscape in the coming year: Congress' approval of language to redefine lawful hemp nationwide and a presidential executive order directing the administration to loosen federal restrictions on marijuana for the first time in over five decades.
-
January 02, 2026
California Cases To Watch In 2026
Legal experts following California courts in 2026 are tracking high-stakes personal injury, antitrust and copyright battles against giants in the social media, artificial intelligence and entertainment industries, as well as wide-ranging legal disputes arising from Los Angeles wildfires and high-profile appeals pending before the California Supreme Court.
-
January 02, 2026
Florida Cases To Watch In 2026
All eyes will be on the Eleventh Circuit in 2026 as it decides what to do with a Florida federal judge's decision determining that the qui tam provision of the False Claims Act is unconstitutional, but Florida appellate courts will also be grappling with the punitive damages framework in the state and the retroactive application of statutory amendments. Here, Law360 looks at cases attorneys in Florida will be watching in 2026.
-
January 02, 2026
New Jersey Cases To Watch In 2026
In the coming year, New Jersey litigators will be watching for the outcome of an appeal in a constitutional challenge to school segregation and an employment discrimination case brought by a former Johnson & Johnson attorney.
-
January 02, 2026
Personal Injury, Medical Malpractice Cases To Watch In 2026
Multidistrict litigation against the biggest tech companies over purported social media addiction and a U.S. Supreme Court case regarding state medical malpractice lawsuit requirements are among those that injury and malpractice attorneys will be following closely in 2026.
-
January 02, 2026
California Legislation And Regulations To Watch In 2026
Legal experts expect California lawmakers and regulators to continue to grapple with the artificial intelligence boom, various battles with the Trump administration and new climate disclosure requirements in 2026. Here's a short list of the major developments that Golden State attorneys will be watching.
-
January 02, 2026
Gov't Contracts Cases To Watch In 2026
The U.S. Supreme Court is poised to answer whether government contractors can immediately appeal denials of immunity, while also deciding whether to tackle the question of who qualifies as an interested party capable of lodging a bid protest. Here, Law360 previews key disputes that government contractors should have on their radar in 2026.
-
January 02, 2026
What To Watch In Massachusetts Courts In 2026
Massachusetts attorneys have their eye on Trump administration policy challenges, state ballot question disputes and False Claims Act enforcement shifts as the calendar turns to 2026.
-
January 02, 2026
SnapChat, Pork And Big Prosecutions: Trials To Watch In 2026
The coming year is set to bring high-profile trials, including in the criminal case against SCOTUSblog co-founder Tom Goldstein, as well as bellwether trials in multidistrict litigation concerning social media's effects on mental health and allegations of price-fixing in the generic-drug industry.
-
January 02, 2026
Pennsylvania Cases To Watch In 2026
As winter's chill rings in the new year, several high-profile cases are set to heat up Pennsylvania's dockets in 2026, including disciplinary charges against a judge associated with rapper Meek Mill, a pending appeals decision on the lawfulness of semiautomatic rifles, and Philadelphia's quest to hold pharmacy benefit managers accountable for the opioid epidemic.
-
January 02, 2026
5 White Collar Enforcement Trends To Watch In 2026
Shifts in white collar enforcement priorities during President Donald Trump's second term in office will pave the way for more changes in the year ahead, as experts predict a ramping up of enforcement actions related to everything from healthcare fraud and tariff evasion to cartels and artificial intelligence.
-
January 02, 2026
Pennsylvania Legislation To Watch In 2026
After belatedly passing a budget for the rest of the fiscal year, Pennsylvania's General Assembly is turning its focus to proposals that would expand liability for data breaches and create a new method for designing voter maps.
-
January 02, 2026
Milbank PE Co-Head On What Will Drive Deals In 2026
With private equity players hoping for a more active 2026, attorneys are increasingly helping sponsors navigate AI-related diligence, defense sector dealmaking and ongoing liquidity pressure in a market where geopolitical uncertainty and valuation gaps still complicate traditional exits.
-
January 02, 2026
The High-Stakes Healthcare AI Battles To Watch In 2026
Courts across the country are set to hear a wave of litigation in the coming year that will begin to draw the legal boundaries around artificial intelligence in healthcare and the life sciences. Law360 spoke with legal experts about the high-stakes AI litigation set to unfold in 2026.
-
January 01, 2026
4 High Court Cases To Watch This Spring
The U.S. Supreme Court justices will return from the winter holidays to tackle several constitutional disputes that range from who is entitled to birthright citizenship to whether transgender individuals are entitled to heightened levels of protection from discrimination.
-
January 01, 2026
Blue Slip Fight Looms Over Trump's 2026 Judicial Outlook
In 2025, President Donald Trump put 20 district and six circuit judges on the federal bench. In the year ahead, a fight over home state senators' ability to block district court picks could make it more difficult for him to match that record.
-
January 01, 2026
BigLaw Leaders Tackle Growth, AI, Remote Work In New Year
Rapid business growth, cultural changes caused by remote work and generative AI are creating challenges and opportunities for law firm leaders going into the New Year. Here, seven top firm leaders share what’s running through their minds as they lie awake at night.
-
December 23, 2025
Trump Admin Beats Chamber Suit Over $100K H-1B Visa Fee
A Washington, D.C., federal judge on Tuesday refused to block the Trump administration's new $100,000 H-1B visa fee, ruling in the U.S. Chamber of Commerce's lawsuit challenging the fee that President Donald Trump has "broad authority" to restrict noncitizens' entry.
-
December 23, 2025
Top Illinois Decisions Of 2025
State and federal courts have handed down rulings in Illinois cases this year that made clear plaintiffs must allege concrete injury for common law standing, narrowed the scope of the federal anti-kickback statute and laid out a new standard for certifying collective actions.
-
December 23, 2025
Philly Joins MDL Against Drug Cos., PBMs Over Insulin Prices
Philadelphia on Tuesday sued drug manufacturers Eli Lilly, Novo Nordisk and Sanofi, along with several pharmacy benefit managers, joining multidistrict litigation in New Jersey federal court accusing the companies of illegally inflating the price of insulin.
-
December 23, 2025
Full 9th Circ. Won't Hear Ex-Theranos Exec Balwani's Appeal
A Ninth Circuit panel rejected ex-Theranos executive Ramesh "Sunny" Balwani's en banc hearing request to reconsider his 12-count conviction and nearly 13-year prison sentence, while also amending its opinion to clarify that there was "ample evidence" to convict Balwani, even if prosecutors failed to correct a witness's testimony.
-
December 23, 2025
Justices Urged To Spurn SG's Call To Tackle 'Skinny Labels'
Amarin Pharma Inc. on Tuesday urged the U.S. Supreme Court to reject the U.S. solicitor general's call to hear a patent case involving generic drug "skinny labels," saying the dispute over the company's heart drug Vascepa deals with factual issues not suitable for high court review.
-
December 23, 2025
AdaptHealth To Pay Investors $35M To End Inflated-Sales Suit
Medical device provider AdaptHealth Corp. has agreed to pay $35 million to settle a lawsuit accusing it of deceiving shareholders about its revenue projections as it "routinely engaged in improper and unethical tactics to inflate sales numbers."
-
December 23, 2025
Squires Will Review If Hydrafacial's ITC Win Should End IPR
U.S. Patent and Trademark Office Director John Squires has paused the Patent Trial and Appeal Board's review of a Hydrafacial LLC skin treatment patent to consider the effect of a related U.S. International Trade Commission decision.
-
December 23, 2025
Top North Carolina Cases Of 2025
A sweep of settlements in major lawsuits punctuated the second half of the year in North Carolina, from a record-breaking wrongful death deal to an eleventh-hour resolution in a lending fight over a biogas development project. Here are some of the top North Carolina case outcomes in the second half of 2025.
Expert Analysis
-
Transmission Security Has A Critical Role In Healthcare
In light of the U.S. Department of Health and Human Services' Office of Civil Rights' continuing enforcement initiative focusing on businesses' accurate and thorough security risk assessments under the Health Insurance Portability and Accountability Act, covered entities should not neglect the importance of transmission security, says John Howard at Clark Hill.
-
Rebutting Price Impact In Securities Class Actions
Defendants litigating securities cases historically faced long odds in defeating class certification, but that paradigm has recently begun to shift, with recent cases ushering in a more searching analysis of price impact and changing the evidence courts can consider at the class certification stage, say attorneys at Katten.
-
7 Document Review Concepts New Attorneys Need To Know
For new associates joining firms this fall, stepping into the world of e-discovery can feel like learning a new language, but understanding a handful of fundamentals — from coding layouts to metadata — can help attorneys become fluent in document review, says Ann Motl at Bowman and Brooke.
-
FTC Actions Highlight New Noncompete Enforcement Strategy
Several recent noncompete-related actions from the Federal Trade Commission — including its recent dismissal of cases appealing the vacatur of a Biden-era noncompete ban — reflect the commission's shift toward case-by-case enforcement, while confirming that the agency intends to remain active in policing such agreements, say attorneys at Debevoise.
-
Ruling On Labor Peace Law Marks Shift For Cannabis Cos.
Currently on appeal to the Ninth Circuit, an Oregon federal court’s novel decision in Casala v. Kotek, invalidating a state law that requires labor peace agreements as a condition of cannabis business licensure, marks the potential for compliance uncertainty for all cannabis employers in states with labor peace mandates, say attorneys at Sheppard Mullin.
-
Deference Ruling Could Close The FAR Loophole
A recent U.S. Court of Federal Claims decision may close a loophole in the Federal Acquisition Regulation that allows agencies to circumvent the Trade Agreements Act, significantly affecting federal pharmaceutical procurements and increasing protests related to certain Buy American Act waivers, say attorneys at Polsinelli.
-
Agentic AI Puts A New Twist On Attorney Ethics Obligations
As lawyers increasingly use autonomous artificial intelligence agents, disciplinary authorities must decide whether attorney responsibility for an AI-caused legal ethics violation is personal or supervisory, and firms must enact strong policies regarding agentic AI use and supervision, says Grace Wynn at HWG.
-
When AI Denies, Insurance Bad Faith Claims May Follow
Two recent rulings from Minnesota and Kentucky federal courts signal that past statements about claims-handling practices may leave insurers using artificial intelligence programs in claims administration vulnerable to suits alleging bad faith and unfair trade practices, say attorneys at Cozen O'Connor.
-
Health Insurance Kickback Cases Signal Greater Gov't Focus
A series of recent indictments by federal prosecutors in California suggests that the Eliminating Kickbacks in Recovery Act is gaining momentum as an enforcement tool against illegal inducement of patient referrals in the realm of commercial health insurance, say attorneys at BakerHostetler.
-
FDA Transparency Plans Raise Investor Disclosure Red Flags
The U.S. Food and Drug Administration’s recently announced intent to publish complete response letters for unapproved drugs and devices implicates certain investor disclosure requirements under securities laws, making it necessary for life sciences and biotech companies to adopt robust controls going forward, say attorneys at Arnold & Porter.
-
Series
Being A Professional Wrestler Makes Me A Better Lawyer
Pursuing my childhood dream of being a professional wrestler has taught me important legal career lessons about communication, adaptability, oral advocacy and professionalism, says Christopher Freiberg at Midwest Disability.
-
Series
Law School's Missed Lessons: Adapting To The Age Of AI
Though law school may not have specifically taught us how to use generative artificial intelligence to help with our daily legal tasks, it did provide us the mental building blocks necessary for adapting to this new technology — and the judgment to discern what shouldn’t be automated, says Pamela Dorian at Cozen O'Connor.
-
Ch. 11 Ruling Voiding $2M Litigation Funding Sends A Warning
A recent Texas bankruptcy court decision that a postconfirmation litigation trust has no obligations to repay a completely drawn down $2 million litigation funding agreement serves as a warning for estate administrators and funders to properly disclose the intended financing, say attorneys at Kleinberg Kaplan.
-
DOJ's Novel Cybersecurity FCA Case Is A Warning To Medtech
The U.S. Department of Justice's recent False Claims Act settlement with Illumina over alleged cybersecurity deficiencies suggests that enforcement agencies and whistleblowers are focusing attention toward cybersecurity in life sciences and medical tech, but also reveals key unanswered questions about the legal viability of such allegations, say attorneys at Morgan Lewis.
-
Demystifying The Civil Procedure Rules Amendment Process
Every year, an advisory committee receives dozens of proposals to amend the Federal Rules of Civil Procedure, most of which are never adopted — but a few pointers can help maximize the likelihood that an amendment will be adopted, says Josh Gardner at DLA Piper.